Product Code: ETC070009 | Publication Date: Aug 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
In the realm of Cell and Gene Therapy Manufacturing, Vietnam is witnessing a surge in contract manufacturing services. With the growing focus on personalized medicine and advanced therapies, contract manufacturers are playing a pivotal role in helping companies bring innovative cell and gene therapies to market.
The Vietnam Contract Cell and Gene Therapy Manufacturing Market are being driven by the rising demand for personalized and advanced therapies. Cell and gene therapies have shown significant potential in treating various diseases and conditions, and the market is witnessing increased investment in research and development. Contract manufacturing organizations (CMOs) specialized in cell and gene therapy manufacturing offer the expertise, facilities, and scalability needed to support the development and production of these innovative therapies. Furthermore, supportive government policies, growing collaborations between biopharmaceutical companies and CMOs, and advancements in biotechnology are driving the expansion of the contract cell and gene therapy manufacturing market in Vietnam.
The Vietnam Contract Cell and Gene Therapy Manufacturing Market face challenges concerning the high costs and specialized expertise required for manufacturing these advanced therapies. Establishing and maintaining state-of-the-art facilities equipped to handle the unique requirements of cell and gene therapy production demands significant investment. Moreover, attracting and retaining skilled personnel with expertise in this rapidly evolving field is essential to ensure the successful implementation of manufacturing projects.
The COVID-19 pandemic had limited immediate impact on the Vietnam Contract Cell and Gene Therapy Manufacturing Market, given its early-stage development in the country. However, the pandemic highlighted the importance of advanced therapies and personalized medicine, further promoting the interest in cell and gene therapy research and manufacturing. As the field of cell and gene therapy continues to evolve and gain regulatory approval, contract manufacturing organizations are likely to play an essential role in supporting the development and commercialization of these innovative treatments. Post-pandemic, the market is expected to see increased investments in biomanufacturing capabilities and partnerships between international CMOs and Vietnamese research institutions to address the growing demand for cell and gene therapy manufacturing services.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F |
3.6 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Vietnam Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Vietnam Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2018 - 2031F |
6.1.3 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2018 - 2031F |
6.1.4 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2018 - 2031F |
6.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2018 - 2031F |
6.2.3 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2018 - 2031F |
6.2.4 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2018 - 2031F |
6.2.5 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2018 - 2031F |
7 Vietnam Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Vietnam Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
9 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F |
9.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Vietnam Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Vietnam Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |